Tamoxifen


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0000084 Mitotic s phase Increases phenotype PMID:30467747; PMID:32530119
GO:0000086 G2/m transition of mitotic cell cycle Decreases phenotype PMID:30467747; PMID:30467747; PMID:32530119; PMID:32530119
GO:0000165 Mapk cascade Increases phenotype PMID:14645110
GO:0000278 Mitotic cell cycle Decreases phenotype PMID:10785588; PMID:30467747; PMID:30664189
GO:0001552 Ovarian follicle atresia Increases phenotype PMID:27395752
GO:0001553 Luteinization Decreases phenotype PMID:27395752; PMID:28248286
GO:0002027 Regulation of heart rate Affects phenotype PMID:29571322
GO:0002523 Leukocyte migration involved in inflammatory response Increases phenotype PMID:29571322; PMID:29974145
GO:0004364 Glutathione transferase activity Increases phenotype PMID:38779996
GO:0004457 Lactate dehydrogenase activity Increases phenotype PMID:38779996
GO:0004510 Tryptophan 5-monooxygenase activity Affects phenotype PMID:28463726
GO:0005262 Calcium channel activity Affects phenotype PMID:24205315
GO:0006094 Gluconeogenesis Decreases phenotype PMID:21570382
GO:0006096 Glycolytic process Affects phenotype PMID:1525059; PMID:21570382
GO:0006106 Fumarate metabolic process Affects phenotype PMID:29974145
GO:0006304 Dna modification Increases phenotype PMID:25123088
GO:0006306 Dna methylation Decreases phenotype PMID:17219426
GO:0006606 Protein import into nucleus Affects phenotype PMID:26470790
GO:0006641 Triglyceride metabolic process Affects phenotype PMID:38191086
GO:0006646 Phosphatidylethanolamine biosynthetic process Affects phenotype PMID:28138993
GO:0006656 Phosphatidylcholine biosynthetic process Decreases phenotype PMID:28138993
GO:0006661 Phosphatidylinositol biosynthetic process Increases phenotype PMID:28138993
GO:0006749 Glutathione metabolic process Affects phenotype PMID:29183790; PMID:32530119
GO:0006805 Xenobiotic metabolic process Increases phenotype PMID:29162470
GO:0006809 Nitric oxide biosynthetic process Increases phenotype PMID:31416231
GO:0006811 Monoatomic ion transport Increases phenotype PMID:10991979
GO:0006884 Cell volume homeostasis Increases phenotype PMID:22108225
GO:0006914 Autophagy Affects phenotype PMID:11872957; PMID:18172760; PMID:18172760; PMID:21233418; PMID:20594311
GO:0006915 Apoptotic process Increases phenotype PMID:10771088; PMID:10785588; PMID:11356682; PMID:11485825; PMID:12169386; PMID:12602925; PMID:12611458; PMID:12611458; PMID:12721755; PMID:17011908; PMID:17767197; PMID:18172760; PMID:18815881; PMID:21233418; PMID:12721755; PMID:12747936; PMID:12810152; PMID:14649542; PMID:14990993; PMID:15604281; PMID:15604281; PMID:9329022; PMID:15606891; PMID:15748701; PMID:16497877; PMID:17011908; PMID:17186241; PMID:17767197; PMID:18172760; PMID:18790785; PMID:18815881; PMID:19931998; PMID:20594311; PMID:21413024; PMID:23840623; PMID:25301941; PMID:30153467; PMID:30467747; PMID:30980508; PMID:32530119; PMID:38779996; PMID:39561883; PMID:27163517; PMID:30153467; PMID:30467747; PMID:30980508; PMID:32530119; PMID:34463000; PMID:39561883; PMID:9742967; PMID:9888466
GO:0006936 Muscle contraction Increases phenotype PMID:28138957
GO:0006974 Cellular response to dna damage stimulus Increases phenotype PMID:30153467
GO:0006979 Response to oxidative stress Increases phenotype PMID:31532279; PMID:9888466
GO:0007049 Cell cycle Increases phenotype PMID:11485825; PMID:12602925; PMID:14645110; PMID:15665275; PMID:16450001; PMID:17186241; PMID:17767197; PMID:17876043; PMID:20225760; PMID:7753712
GO:0007283 Spermatogenesis Increases phenotype PMID:34974146; PMID:8070710
GO:0007565 Female pregnancy Decreases phenotype PMID:28248286
GO:0007585 Respiratory gaseous exchange by respiratory system Decreases phenotype PMID:29571322
GO:0007613 Memory Decreases phenotype PMID:24902786; PMID:37392961
GO:0007614 Short-term memory Decreases phenotype PMID:24902786
GO:0007616 Long-term memory Decreases phenotype PMID:24902786
GO:0008219 Cell death Increases phenotype PMID:10715583; PMID:11034078; PMID:12632256; PMID:12894523; PMID:14645110; PMID:15190103; PMID:16450001; PMID:16497877; PMID:18167132; PMID:19330798; PMID:28322778; PMID:7753712
GO:0008283 Cell population proliferation Increases phenotype PMID:10505046; PMID:11485825; PMID:11735166; PMID:12169386; PMID:12602925; PMID:12611458; PMID:17186241; PMID:17876043; PMID:20225760; PMID:2386944; PMID:2846159; PMID:3458212; PMID:6542011; PMID:12632256; PMID:12894523; PMID:1333883; PMID:15642790; PMID:15665275; PMID:15750629; PMID:16263272; PMID:1661414; PMID:1661414; PMID:21513275; PMID:17186241; PMID:17219426; PMID:17458902; PMID:24213142; PMID:30664189; PMID:17572228; PMID:17876043; PMID:18066117; PMID:18066117; PMID:6542011; PMID:8110496; PMID:18575591; PMID:18575591; PMID:21513275; PMID:9714066; PMID:19031437; PMID:19549922; PMID:19874578; PMID:20225760; PMID:20302909; PMID:20535544; PMID:21413024; PMID:21513275; PMID:21513275; PMID:24758408; PMID:25301941; PMID:22138011; PMID:28763032; PMID:23786776; PMID:2386944; PMID:24758408; PMID:25301941; PMID:27163517; PMID:2936615; PMID:30664189; PMID:3458212; PMID:7588234; PMID:7923186; PMID:8110496; PMID:9888466
GO:0008284 Positive regulation of cell population proliferation Affects phenotype PMID:22108225; PMID:28811679; PMID:32171938; PMID:34270681; PMID:34821461; PMID:9224209
GO:0008285 Negative regulation of cell population proliferation Increases phenotype PMID:21687957; PMID:22037685; PMID:23159075; PMID:32497533; PMID:34821461
GO:0008584 Male gonad development Decreases phenotype PMID:23213263
GO:0008585 Female gonad development Decreases phenotype PMID:28248286
GO:0008610 Lipid biosynthetic process Increases phenotype PMID:27089845
GO:0008654 Phospholipid biosynthetic process Affects phenotype PMID:28138993; PMID:28552552
GO:0009086 Methionine biosynthetic process Affects phenotype PMID:29974145
GO:0010694 Positive regulation of alkaline phosphatase activity Increases phenotype PMID:27159630
GO:0010729 Positive regulation of hydrogen peroxide biosynthetic process Increases phenotype PMID:15545282
GO:0010825 Positive regulation of centrosome duplication Increases phenotype PMID:27998958
GO:0010918 Positive regulation of mitochondrial membrane potential Increases phenotype PMID:15545282
GO:0010942 Positive regulation of cell death Increases phenotype PMID:15545282; PMID:23397584
GO:0014734 Skeletal muscle hypertrophy Increases phenotype PMID:29571322
GO:0016049 Cell growth Decreases phenotype PMID:30153467
GO:0019249 Lactate biosynthetic process Decreases phenotype PMID:29974145
GO:0019432 Triglyceride biosynthetic process Decreases phenotype PMID:28138993
GO:0019722 Calcium-mediated signaling Increases phenotype PMID:11034078; PMID:11034078; PMID:15604281; PMID:11034078; PMID:17011908; PMID:12632256; PMID:17011908; PMID:21413024
GO:0019853 L-ascorbic acid biosynthetic process Decreases phenotype PMID:29974145
GO:0022832 Voltage-gated channel activity Affects phenotype PMID:33512997
GO:0030199 Collagen fibril organization Increases phenotype PMID:29571322
GO:0030282 Bone mineralization Decreases phenotype PMID:29571322
GO:0030335 Positive regulation of cell migration Increases phenotype PMID:34821461
GO:0030336 Negative regulation of cell migration Increases phenotype PMID:34270681; PMID:34821461
GO:0030520 Intracellular estrogen receptor signaling pathway Increases phenotype PMID:36513145
GO:0031324 Negative regulation of cellular metabolic process Increases phenotype PMID:29445054
GO:0032049 Cardiolipin biosynthetic process Increases phenotype PMID:28138993
GO:0032148 Activation of protein kinase b activity Increases phenotype PMID:34821461
GO:0032735 Positive regulation of interleukin-12 production Increases phenotype PMID:28811679
GO:0032792 Negative regulation of creb transcription factor activity Increases phenotype PMID:37392961
GO:0032930 Positive regulation of superoxide anion generation Increases phenotype PMID:15545282
GO:0034383 Low-density lipoprotein particle clearance Affects phenotype PMID:27358406
GO:0034440 Lipid oxidation Increases phenotype PMID:29183790; PMID:38779996
GO:0035847 Uterine epithelium development Increases phenotype PMID:24487097
GO:0036164 Cell-abiotic substrate adhesion Decreases phenotype PMID:33024228
GO:0040011 Locomotion Affects phenotype PMID:29571322
GO:0040015 Negative regulation of multicellular organism growth Increases phenotype PMID:30672060
GO:0042307 Positive regulation of protein import into nucleus Increases phenotype PMID:27358406
GO:0042311 Vasodilation Increases phenotype PMID:21092740
GO:0042412 Taurine biosynthetic process Decreases phenotype PMID:29974145
GO:0042420 Dopamine catabolic process Affects phenotype PMID:28463726
GO:0042422 Norepinephrine catabolic process Affects phenotype PMID:28463726
GO:0042429 Serotonin catabolic process Affects phenotype PMID:28463726
GO:0042554 Superoxide anion generation Increases phenotype PMID:12628514
GO:0042755 Eating behavior Affects phenotype PMID:38191086
GO:0043065 Positive regulation of apoptotic process Increases phenotype PMID:21413024; PMID:22646800; PMID:34821461; PMID:35468944
GO:0043066 Negative regulation of apoptotic process Increases phenotype PMID:34821461
GO:0044237 Cellular metabolic process Increases phenotype PMID:15149724; PMID:15196704; PMID:30467747; PMID:30980508; PMID:31576639; PMID:32530119; PMID:39561883; PMID:22905168; PMID:29940172; PMID:30467747; PMID:30980508; PMID:31576639; PMID:32530119; PMID:34463000; PMID:39561883
GO:0044319 Wound healing, spreading of cells Decreases phenotype PMID:30153467; PMID:32530119; PMID:32530119
GO:0044849 Estrous cycle Decreases phenotype PMID:27395752
GO:0045023 G0 to g1 transition Affects phenotype PMID:30467747; PMID:30467747; PMID:30980508; PMID:32530119; PMID:30980508; PMID:32530119
GO:0045429 Positive regulation of nitric oxide biosynthetic process Increases phenotype PMID:15545282
GO:0045795 Positive regulation of cell volume Increases phenotype PMID:21792908; PMID:22108225; PMID:22108225
GO:0045930 Negative regulation of mitotic cell cycle Increases phenotype PMID:30153467; PMID:30153467; PMID:30467747; PMID:30980508; PMID:32530119; PMID:30467747; PMID:30467747; PMID:30980508; PMID:32530119; PMID:30467747; PMID:32530119; PMID:30980508; PMID:32530119
GO:0046058 Camp metabolic process Affects phenotype PMID:27936172
GO:0046323 Glucose import Affects phenotype PMID:38779996
GO:0046466 Membrane lipid catabolic process Affects phenotype PMID:17283165; PMID:1884432; PMID:31532279; PMID:8494544
GO:0046620 Regulation of organ growth Affects phenotype PMID:27395752
GO:0046622 Positive regulation of organ growth Affects phenotype PMID:27395752
GO:0046649 Lymphocyte activation Decreases phenotype PMID:19031437
GO:0046716 Muscle cell cellular homeostasis Affects phenotype PMID:29571322
GO:0050729 Positive regulation of inflammatory response Increases phenotype PMID:35468944
GO:0051298 Centrosome duplication Increases phenotype PMID:36384894
GO:0051881 Regulation of mitochondrial membrane potential Decreases phenotype PMID:14990993; PMID:17283165; PMID:20225760; PMID:27089845; PMID:32530119
GO:0051882 Mitochondrial depolarization Increases phenotype PMID:21413024
GO:0051898 Negative regulation of protein kinase b signaling Increases phenotype PMID:37392961
GO:0055119 Relaxation of cardiac muscle Affects phenotype PMID:24205315
GO:0060004 Reflex Decreases phenotype PMID:25595991
GO:0060065 Uterus development Decreases phenotype PMID:28248286
GO:0060326 Cell chemotaxis Decreases phenotype PMID:32530119
GO:0070265 Necrotic cell death Increases phenotype PMID:29571322; PMID:29974145
GO:0070374 Positive regulation of erk1 and erk2 cascade Increases phenotype PMID:27358406
GO:0070782 Phosphatidylserine exposure on apoptotic cell surface Increases phenotype PMID:15545282
GO:0070873 Regulation of glycogen metabolic process Affects phenotype PMID:30672060
GO:0070994 Detection of oxidative stress Increases phenotype PMID:24486436
GO:0071466 Cellular response to xenobiotic stimulus Increases phenotype PMID:32497533
GO:0072593 Reactive oxygen species metabolic process Increases phenotype PMID:32530119; PMID:34463000; PMID:38779996
GO:0086003 Cardiac muscle cell contraction Affects phenotype PMID:24205315
GO:0090327 Negative regulation of locomotion involved in locomotory behavior Increases phenotype PMID:29183790
GO:0097327 Response to antineoplastic agent Increases phenotype PMID:26078298; PMID:32001260
GO:0140042 Lipid droplet formation Increases phenotype PMID:38191086
GO:0140354 Lipid import into cell Increases phenotype PMID:35944649
GO:1900087 Positive regulation of g1/s transition of mitotic cell cycle Increases phenotype PMID:34821461
GO:1901216 Positive regulation of neuron death Increases phenotype PMID:29183790
GO:1902476 Chloride transmembrane transport Affects phenotype PMID:21792908; PMID:22108225; PMID:22108225
GO:1902512 Positive regulation of apoptotic dna fragmentation Increases phenotype PMID:21413024
GO:1902608 Positive regulation of large conductance calcium-activated potassium channel activity Increases phenotype PMID:21413024
GO:1902941 Regulation of voltage-gated chloride channel activity Affects phenotype PMID:33512997
GO:1903047 Mitotic cell cycle process Affects phenotype PMID:38779996
GO:1903409 Reactive oxygen species biosynthetic process Increases phenotype PMID:27089845; PMID:30153467
GO:1903428 Positive regulation of reactive oxygen species biosynthetic process Increases phenotype PMID:34821461
GO:1903709 Uterine gland development Affects phenotype PMID:24487097; PMID:27395752
GO:1903999 Negative regulation of eating behavior Increases phenotype PMID:30672060
GO:1904109 Positive regulation of cholesterol import Increases phenotype PMID:35944649
GO:1905602 Positive regulation of receptor-mediated endocytosis involved in cholesterol transport Increases phenotype PMID:35944649
GO:1905867 Epididymis development Affects phenotype PMID:34974146
GO:2000134 Negative regulation of g1/s transition of mitotic cell cycle Increases phenotype PMID:34821461
GO:2000386 Positive regulation of ovarian follicle development Decreases phenotype PMID:28248286
GO:2001024 Negative regulation of response to drug Increases phenotype PMID:34821461
GO:2001200 Positive regulation of dendritic cell differentiation Increases phenotype PMID:28811679

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.